Latest filing published 23 Jun 2025 for Axsome Therapeutics, Inc., €668k.
Filing timeline
BuySaleInsider track record
Hunter R. Murdock: trading record in brief
Hunter R. Murdock is a declared insider of Axsome Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 16 June 2025 to 23 June 2025, the count stands at 10 filings.
Every open-market trade on record is a sale: 5 sales worth €3.2M. The rest of the record consists of 5 option exercises.
The latest filing, published on 23 June 2025, reports an open-market sale of €668k in Axsome Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Hunter R. Murdock
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500 shares@ US$102.4716.3% of flowCommon StockSEC:0000950170-25-089158:1
- 6,014 shares@ US$29.913.8% of flowCommon StockSEC:0000950170-25-089158:2
- 6,014 shares@ US$100.1212.7% of flowCommon StockSEC:0000950170-25-089158:3
- 7,500 shares@ US$29.9150.1% of flowCommon StockSEC:0000950170-25-089158:0
- 7,500 shares@ US$102.4216.2% of flowCommon StockSEC:0000950170-25-088105:1
- 7,500 shares@ US$29.914.8% of flowCommon StockSEC:0000950170-25-088105:2
- 7,500 shares@ US$100.2616.0% of flowCommon StockSEC:0000950170-25-088105:3
- 7,500 shares@ US$29.914.8% of flowCommon StockSEC:0000950170-25-088105:4
- 7,500 shares@ US$100.9016.1% of flowCommon StockSEC:0000950170-25-088105:5
- 7,500 shares@ US$29.9149.9% of flowCommon StockSEC:0000950170-25-088105:0
10 of 10 declarations
